Skip to search formSkip to main contentSkip to account menu

aripiprazole

Known as: Aripiprazol, 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone, Aripiprazole [Chemical/Ingredient] 
A quinoline derivate and atypical anti-psychotic agent. Aripiprazole has partial agonistic activity at dopamine D2 receptors and serotonin 5-HT1A… 
National Institutes of Health

Related topics

Related topics

25 relations
1.5 ML aripiprazole 200 MG/ML Prefilled Syringe1.6 ML aripiprazole lauroxil 276 MG/ML Prefilled SyringeAripiprazole cutoff:MCnc:Pt:Urine:Qn:ConfirmAripiprazole:MCnc:Pt:Ser/Plas:Qn

Narrower (4)

AbilifyAbilitatOPC 14597aripiprazole lauroxil

Broader (1)

Antipsychotic Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Contributing factors to weight gain during long‐term treatment with second‐generation antipsychotics. A systematic appraisal and clinical implications
The increased rates of both overweight and obesity reported in severely mentally‐ill patients are prevalently due to the use of… 
2009
2009
Aripiprazole in the pharmacotherapy of Gilles de la Tourette syndrome in adult patients
Despite the ongoing development of neuroleptics, typical or first-generation neuroleptics are still considered as the first… 
Highly Cited
2008
Highly Cited
2008
Improvement of phencyclidine-induced social behaviour deficits in rats: Involvement of 5-HT1A receptors
Highly Cited
2008
Highly Cited
2008
Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
Review
2008
Review
2008
Successful treatment of tardive lingual dystonia with botulinum toxin: Case report and review of the literature
2007
2007
Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: Implication for glutamatergic postsynaptic density in…
Review
2007
Review
2007
Management of agitation in the acute psychotic patient — Efficacy without excessive sedation
Highly Cited
2006
Highly Cited
2006
Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase.
2006
2006
Aripiprazole-Related Tardive Dyskinesia
ABSTRACT The low prevalence of extrapyramidal symptoms associated with atypical antipsychotics has led to their widespread use… 
Review
2002
Review
2002
Advances in Atypical Antipsychotics for the Treatment of Schizophrenia
Innovation in atypical antipsychotic agents continues with new preparations of available drugs as well as novel agents. In this… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)